Invenra
PrivateLast Round
Debt
Apr 10, 2020
Total Funding Raised
$19.84M
Company Overview
Invenra is a biotechnology company that specializes in the discovery and development of next-generation multispecific antibody therapeutics for oncology and other disease applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Invenra Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Invenra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 10, 2020 | ||||
| Series B | Oct 16, 2018 | ||||
| Series A | Oct 5, 2017 | ||||
| Series A Extension | Jul 20, 2016 | ||||
| Series A Extension | Aug 13, 2015 | ||||
VC Round | Jan 28, 2015 |
Invenra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rose Ventures Inc. | Series A |
| State of Wisconsin Investment Board | Series B |
| Venture Investors LLC | Series B |
| State of Wisconsin Investment Board (SWIB) | Series B |
| Venture Management, LLC | Series A Extension |
| Wisconsin Investment Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2025
Partnering with Xcellon Biologics to develop new antibody therapeutics.
- Jul 14, 2025
Dr. Alan J. Korman joins the Scientific Advisory Board.
Invenra Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Invenra's valuation, stock price, and market status.